Guidance for the evaluation and treatment of hereditary and acquired thrombophilia - Wikidata - wikimedia - TriplyDB

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

http://www.wikidata.org/entity/Q28077943

about

Recurrent pregnancy loss: current perspectives Thrombophilia with an onset symptom of intracranial venous thrombosis: A case report and review of the literature Management of idiopathic venous thromboembolism.Utility of thrombophilia testing in patients with venous thrombo-embolism Oral Contraceptives and HRT Risk of Thrombosis.Thrombophilia-Associated Factors in Patients with Spontaneous Osteonecrosis of the Knee.In Reference to: "Cost and Utility of Thrombophilia Testing".Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma.What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies The role of thrombophilia testing in women with adverse pregnancy outcomes

P2860

Q33713930-4231105F-39B5-4D1D-8B5F-E747EA15A013 Q33744030-3B8ACD3B-A862-4569-9453-80A1237A6938 Q38980480-D1F8786D-7BED-40F9-90EA-1545B13B88E0 Q38985404-E2C9B2C0-ADE4-411F-AD14-3A8F530D2CE8 Q39066094-238D7673-4FFB-4DA9-95C9-3770E96695B0 Q47225542-9B1A3463-CED7-47E8-865B-01ED9A252D4B Q47732323-417F646A-0C1C-44E2-8B8C-AFE11B7DB06C Q52313102-934D294E-868D-49A4-B119-42A4B86AB1A5 Q57611689-CA3F593F-6172-4B61-BE27-DECBF330CC35 Q58205336-7896DFD7-38A8-41E1-ABDD-EC48852FF9D0

P2860

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

http://www.wikidata.org/entity/Q28077943

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@ast

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@en

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@nl

type

label

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@ast

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@en

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@nl

prefLabel

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@ast

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@en

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@nl

P1433

Q28077943-48567956-6926-40BE-B214-97F274381B64

P1476

Q28077943-91B2B3DE-B0DA-4520-B412-B8E94676EBA8

P2093

Q28077943-36948FDA-47D2-413F-86B7-3901AA5FD6F9

Q28077943-7445B971-4360-4039-A88E-9D79A0FAC8F2

Q28077943-77ED6B6E-FD0C-4D33-A41C-9DF9A26F90BC

Q28077943-868C0D85-0801-422D-81E2-106E83C9793E

Q28077943-AF1982AA-95D5-4B80-9FA1-BC993D078350

Q28077943-D37DD914-98F1-4AA8-A852-C89693E363B3

Q28077943-DE5DE836-5198-42DE-B614-0BC7B7713CD4

P275

Q28077943-088028D3-480B-4755-88EB-948B7EC1BF73

P2860

Q28077943-036386BE-A1D8-4127-8E4F-50056944A779

Q28077943-03AC52E2-10A9-45B9-8B62-3D6A1C4B2FC8

Q28077943-04707C72-C65E-4971-85CA-10C7FE467B56

Q28077943-05D641DA-B5F2-47ED-A2B6-BF404E97F4BF

Q28077943-0E45AC34-F8F1-42B2-9692-FF5C2E6B1D6E

Q28077943-15A40601-3152-49F9-B7FB-B176692AC785

Q28077943-1C3A7D71-0927-4D03-AC4B-21D1E5ED05EA

Q28077943-2124B9A6-68EB-4EF0-AA07-40847215DAD2

Q28077943-22848F9C-A35F-4106-88B0-C6B2466C0D95

Q28077943-25D8FC0F-1F8E-4F7D-84E3-1DCE1834A33A

P2888

Q28077943-E4AADF44-0A39-4E91-988F-41F2837ABB3A

P304

Q28077943-A90638C6-1D96-4AE9-A62A-50397CD8ED5E

P31

Q28077943-10CE6210-C7CC-4F58-B195-077337AB032E

Q28077943-19ABA601-F8CE-4730-96C9-314416FBCA1F

P356

Q28077943-2C4716B6-CC50-4FE3-AF13-840088EB6E67

P407

Q28077943-CC7F784B-B3AD-4765-97BF-6EA9E50BBC54

P433

Q28077943-9890A541-6781-4016-815C-D57B3DA93787

P478

Q28077943-E230B7BC-3889-429F-B04F-0BFF68C094B0

P50

Q28077943-474489B9-C6D2-4976-938B-75750920DB52

P5008

Q28077943-814B8099-386C-498D-918E-09088AAD3C95

P577

Q28077943-0A9C9304-3E6B-4C23-B5BF-C9B8A2CFC8F7

Q28077943-8110FE0B-7C09-4AEC-A7CD-B1FC4F4FE90A

P5875

Q28077943-90427A05-BCD8-4850-B13E-B2AC582874B4

P698

Q28077943-2D70B29B-F9C0-45F4-836D-EA9F2D838ED0

P921

Q28077943-D41CDB45-580F-493D-9609-0E833D8044D6

P932

Q28077943-408F76FA-291C-47AC-B267-4AEBE6F822B9

P356

S11239-015-1316-1

P1433

Journal of Thrombosis and Thrombolysis

P1476

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

@en

P2093

James D. Douketis

http://www.w3.org/2001/XMLSchema#string

Kenneth A. Bauer

http://www.w3.org/2001/XMLSchema#string

Michael Streiff

http://www.w3.org/2001/XMLSchema#string

Raj Kasthuri

http://www.w3.org/2001/XMLSchema#string

Scott C. Woller

http://www.w3.org/2001/XMLSchema#string

Scott M. Stevens

http://www.w3.org/2001/XMLSchema#string

Wendy Lim

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period

Deficiency of protein C in congenital thrombotic disease

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review

Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study

American College of Medical Genetics consensus statement on factor V Leiden mutation testing

P2888

s11239-015-1316-1

P304

154-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-015-1316-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290788487

http://www.w3.org/2001/XMLSchema#string

P698

26780744

http://www.w3.org/2001/XMLSchema#string

P921

P932

4715840

http://www.w3.org/2001/XMLSchema#string